CAPITOL COUNSEL LLC

Lobbying for CONTINUUS PHARMACEUTICALS · Biopharmaceutical manufacturing.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · $60,000.00 income · posted Apr 16, 2026

Lobbying activity 2

Health Issues

Issues regarding incentives to reshore pharmaceutical manufacturing.

Manufacturing

Issues regarding incentives to rehore pharmaceutical manufacturing.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.